Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2342 (LINC02342)
- Target
- LINC02342
- Molecular classification
- Other, Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2342 (LINC02342) is a member of the long intergenic non-coding RNA (lincRNA) family—non-coding RNA genes located in regions of the genome that do not overlap coding sequences[1][7]. LINC02342 is annotated as an RNA gene, but there is currently limited experimentally validated information regarding its precise biological functions or involvement in disease pathways[1]. In general, lincRNAs such as LINC02342 are known to participate in a variety of biological processes, primarily through regulation of gene expression at the transcriptional and epigenetic level[3][7]. There is no available evidence supporting its status as a therapeutic target, nor any known drug interactions, disease biomarker roles, or specific safety concerns. The functional annotation for LINC02342 remains limited; its inclusion in databases reflects genomic and transcriptomic identification rather than validated clinical significance.
- Other names
- LINC02342long intergenic non-protein coding RNA 2342
02
Biological functions
Likely involved in gene regulation (inferred based on lincRNA family)Other (insufficient specific functional data for LINC02342, but lincRNAs have broad regulatory roles)
03
Disease associations
Other (no direct evidence linking LINC02342 to a specific disease)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2342 (LINC02342).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2342 (LINC02342).